Hudson Bay Capital Management
STRO icon

Hudson Bay Capital Management’s Sutro Biopharma STRO Stock Holding History

Hudson Bay Capital Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,768
Closed -$368K – 1679
2026
Q1 		$368K Buy
+14,768
New +$267K ﹤0.01% 1013
2025
Q3 		– Sell
-2,257
Closed -$16.1K – 1653
2025
Q2 		$16.1K Buy
+2,257
New +$18.5K ﹤0.01% 1321
2024
Q3 		– Sell
-6,076
Closed -$178K – 1034
2024
Q2 		$178K Buy
+6,076
New +$240K ﹤0.01% 666
2022
Q1 		– Sell
-10,150
Closed -$1.51M – 1310
2021
Q4 		$1.51M Buy
10,150
+5,150
+103% +$923K 0.02% 732
2021
Q3 		$945K Buy
5,000
+2,500
+100% +$475K 0.01% 761
2021
Q2 		$465K Buy
+2,500
New +$489K 0.01% 798

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Hudson Bay Capital Management's STRO Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Sutro Biopharma (STRO) in Q2 2026, closing a stake of 14,768 shares — an estimated $368K sold.

Hudson Bay Capital Management first reported a position in STRO in Q2 2021 and held it in 6 quarters. The position peaked at $1.51M in Q4 2021. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Sutro Biopharma position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 14,768 Sutro Biopharma shares in Q2 2026, an estimated $368K.
  • Hudson Bay Capital Management first reported a position in Sutro Biopharma in Q2 2021 and held it in 6 quarters.
  • Hudson Bay Capital Management's Sutro Biopharma position peaked at $1.51M in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.